Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Global COE Program, Nagasaki University, Nagasaki, Japan.
J Med Microbiol. 2012 Nov;61(Pt 11):1556-1562. doi: 10.1099/jmm.0.049163-0. Epub 2012 Aug 16.
Rapid identification of the causative bacteria of sepsis in patients can contribute to the selection of appropriate antibiotics and improvement of patients' prognosis. Genotypic identification is an emerging technology that may provide an alternative method to, or complement, established phenotypic identification procedures. We evaluated a rapid protocol for bacterial identification based on PCR and pyrosequencing of the V1 and V3 regions of the 16S rRNA gene using DNA extracted directly from positive blood culture samples. One hundred and two positive blood culture bottles from 68 patients were randomly selected and the bacteria were identified by phenotyping and pyrosequencing. The results of pyrosequencing identification displayed 84.3 and 64.7 % concordance with the results of phenotypic identification at the genus and species levels, respectively. In the monomicrobial samples, the concordance between the results of pyrosequencing and phenotypic identification at the genus level was 87.0 %. Pyrosequencing identified one isolate in 60 % of polymicrobial samples, which were confirmed by culture analysis. Of the samples identified by pyrosequencing, 55.7 % showed consistent results in V1 and V3 targeted sequencing; other samples were identified based on the results of V1 (12.5 %) or V3 (31.8 %) sequencing alone. One isolate was erroneously identified by pyrosequencing due to high sequence similarity with another isolate. Pyrosequencing identified one isolate that was not detected by phenotypic identification. The process of pyrosequencing identification can be completed within ~4 h. The information provided by DNA-pyrosequencing for the identification of micro-organisms in positive blood culture bottles is accurate and could prove to be a rapid and useful tool in standard laboratory practice.
快速鉴定脓毒症患者的致病细菌有助于选择合适的抗生素并改善患者的预后。基因分型鉴定是一种新兴技术,可能提供一种替代或补充已建立的表型鉴定程序的方法。我们评估了一种基于聚合酶链反应(PCR)和 16S rRNA 基因 V1 和 V3 区焦磷酸测序的快速细菌鉴定方案,该方案直接从阳性血培养样本中提取 DNA。随机选择 68 例患者的 102 个阳性血培养瓶,通过表型和焦磷酸测序鉴定细菌。焦磷酸测序鉴定的结果与表型鉴定在属和种水平上的符合率分别为 84.3%和 64.7%。在单微生物样本中,焦磷酸测序与表型鉴定在属水平上的符合率为 87.0%。焦磷酸测序在 60%的混合微生物样本中鉴定出一个分离株,这些分离株通过培养分析得到证实。在焦磷酸测序鉴定的样本中,55.7%在 V1 和 V3 靶向测序中显示一致的结果;其他样本仅根据 V1(12.5%)或 V3(31.8%)测序结果鉴定。由于与另一个分离株具有高度序列相似性,焦磷酸测序错误地鉴定了一个分离株。焦磷酸测序鉴定了一个表型鉴定未检测到的分离株。焦磷酸测序鉴定过程可在~4 小时内完成。阳性血培养瓶中微生物鉴定的 DNA-焦磷酸测序提供的信息准确,有望成为标准实验室实践中的一种快速有用的工具。